Category Press Releases

Vertex

Vertex’s Paul Negulescu, Ph.D., Wins 2025 Gairdner Award for Cystic Fibrosis Breakthroughs

Vertex’s Paul Negulescu, Ph.D., Wins 2025 Gairdner Award for Cystic Fibrosis Breakthroughs In a landmark moment for both Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and the broader scientific community, Paul Negulescu, Ph.D., Senior Vice President at Vertex, has been named a…

Read MoreVertex’s Paul Negulescu, Ph.D., Wins 2025 Gairdner Award for Cystic Fibrosis Breakthroughs
Exicure

Exicure Announces Plans for New Clinical Trial in Acute Myeloid Leukemia (AML)

Exicure Announces Plans for New Clinical Trial in Acute Myeloid Leukemia (AML) Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company focused on developing innovative therapeutics targeting diseases with high unmet medical needs, announced significant updates today regarding its lead investigational…

Read MoreExicure Announces Plans for New Clinical Trial in Acute Myeloid Leukemia (AML)
Signios Bio

Signios Bio Debuts with AI-Powered Multiomics Platform for Precision Medicine and Drug Discovery

Signios Biosciences Unveils Rebrand and Expands Vision as a Leading Multiomics and AI Bioinformatics Innovator in Precision Medicine In a bold step forward reflecting its evolution and expanded capabilities, Signios Biosciences (formerly the U.S.-based research division of MedGenome Inc.) has…

Read MoreSignios Bio Debuts with AI-Powered Multiomics Platform for Precision Medicine and Drug Discovery
Pregnancy

Biologic Therapy Boosts Pregnancy Outcomes in High-Risk APS Patients

Biologic Therapy Boosts Pregnancy Outcomes in High-Risk APS Patients Landmark Clinical Trial Finds Certolizumab Significantly Improves Pregnancy Outcomes in Women with Antiphospholipid Syndrome In a groundbreaking advancement for maternal-fetal medicine and autoimmune disease treatment, a phase 2 clinical trial co-led…

Read MoreBiologic Therapy Boosts Pregnancy Outcomes in High-Risk APS Patients
Wellness

Textron Aviation Opens Second Plane Healthy Wellness Center & Pharmacy in Wichita to Enhance Employee Healthcare Access

Textron Aviation Opens Second Plane Healthy Wellness Center & Pharmacy in Wichita to Enhance Employee Healthcare Access Textron Aviation Inc., a renowned aircraft manufacturer and a subsidiary of Textron Inc. (NYSE: TXT), has announced the opening of its second Plane…

Read MoreTextron Aviation Opens Second Plane Healthy Wellness Center & Pharmacy in Wichita to Enhance Employee Healthcare Access
Therapeutics

Global Forecast: mRNA Vaccines & Therapeutics Market for Influenza, RSV, and CMV (2025)

Global Forecast: mRNA Vaccines & Therapeutics Market for Influenza, RSV, and CMV (2025) A new report titled “mRNA Vaccine and Therapeutics Market: Industry Trends and Global Forecasts to 2035 by Application Area, Target Disease Indication, and Geographical Regions” has been…

Read MoreGlobal Forecast: mRNA Vaccines & Therapeutics Market for Influenza, RSV, and CMV (2025)
IBL

IBL International Partners with Grifols to Develop Cutting-Edge Biomarker Panels

IBL International Partners with Grifols to Develop Cutting-Edge Biomarker Panels IBL International GmbH, a Tecan Group company renowned for its expertise in specialty diagnostics, has officially announced a strategic partnership with Grifols, a global healthcare leader with a legacy in…

Read MoreIBL International Partners with Grifols to Develop Cutting-Edge Biomarker Panels
Alpenglow

Alpenglow Biosciences to Host AACR 2025 Dinner Talk on Spatial Biology in Endometrial Cancer

Alpenglow Biosciences to Host AACR 2025 Dinner Talk on Spatial Biology in Endometrial Cancer Alpenglow Biosciences, a leading innovator in 3D spatial biology and digital pathology, is pleased to announce its exclusive Dinner Lecture during the American Association for Cancer…

Read MoreAlpenglow Biosciences to Host AACR 2025 Dinner Talk on Spatial Biology in Endometrial Cancer
Sail Biomedicines

Sail Biomedicines Welcomes Dr. Laura Sepp-Lorenzino to Its Board of Directors

Sail Biomedicines Welcomes Dr. Laura Sepp-Lorenzino to Its Board of Directors Sail Biomedicines, Inc., a pioneering biotechnology company at the forefront of programmable RNA-based medicines and a Flagship Pioneering-founded enterprise, today announced the appointment of Laura Sepp-Lorenzino, Ph.D., to its…

Read MoreSail Biomedicines Welcomes Dr. Laura Sepp-Lorenzino to Its Board of Directors